NDC 75834-245

LEVETIRACETAM EXTENDED RELEASE

Levetiracetam

LEVETIRACETAM EXTENDED RELEASE is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is Levetiracetam.

Product ID75834-245_69069c2b-6ee3-4003-b547-24d9a7a1b74c
NDC75834-245
Product TypeHuman Prescription Drug
Proprietary NameLEVETIRACETAM EXTENDED RELEASE
Generic NameLevetiracetam
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2020-09-16
Marketing CategoryANDA / DRUG FOR FURTHER PROCESSING
Application NumberANDA201464
Labeler NameNivagen Pharmaceuticals, Inc.
Substance NameLEVETIRACETAM
Active Ingredient Strength500 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 75834-245-05

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (75834-245-05)
Marketing Start Date2020-09-16
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LEVETIRACETAM EXTENDED RELEASE" or generic name "Levetiracetam"

NDCBrand NameGeneric Name
75834-246LEVETIRACETAM EXTENDED RELEASELEVETIRACETAM EXTENDED RELEASE
75834-245LEVETIRACETAM EXTENDED RELEASELEVETIRACETAM EXTENDED RELEASE
0054-0224LevetiracetamLevetiracetam
0121-0799LevetiracetamLEVETIRACETAM
0121-1598LevetiracetamLEVETIRACETAM
0121-2397LevetiracetamLEVETIRACETAM
0121-4799LevetiracetamLEVETIRACETAM
0121-4802LEVETIRACETAMLEVETIRACETAM
0143-9574LevetiracetamLevetiracetam
0143-9673LevetiracetamLevetiracetam
0228-2167LevetiracetamLevetiracetam
0378-5613Levetiracetamlevetiracetam
0378-5615Levetiracetamlevetiracetam
0378-5617Levetiracetamlevetiracetam

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.